News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,398 Results
Type
Article (46146)
Company Profile (334)
Press Release (711889)
Multimedia
Podcasts (159)
Webinars (25)
Section
Business (213153)
Career Advice (2210)
Deals (37312)
Drug Delivery (151)
Drug Development (84778)
Employer Resources (178)
FDA (17086)
Job Trends (15715)
News (361865)
Policy (34683)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2672)
Accelerated approval (46)
Adcomms (36)
Allergies (179)
Alliances (52231)
ALS (216)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (470)
Approvals (17431)
Artificial intelligence (696)
Autoimmune disease (288)
Automation (55)
Bankruptcy (379)
Best Places to Work (11841)
BIOSECURE Act (22)
Biosimilars (232)
Biotechnology (195)
Bladder cancer (187)
Brain cancer (74)
Breast cancer (760)
Cancer (5915)
Cardiovascular disease (502)
Career advice (1872)
Career pathing (46)
CAR-T (336)
CDC (64)
Celiac Disease (3)
Cell therapy (915)
Cervical cancer (46)
Clinical research (73318)
Collaboration (2145)
Company closure (6)
Compensation (1410)
Complete response letters (93)
COVID-19 (2839)
CRISPR (115)
C-suite (1143)
Cystic fibrosis (156)
Data (7810)
Decentralized trials (3)
Denatured (45)
Depression (168)
Dermatology (85)
Diabetes (605)
Diagnostics (7036)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (331)
Drug pricing (235)
Drug shortages (37)
Duchenne muscular dystrophy (289)
Earnings (94054)
Editorial (72)
Employer branding (21)
Employer resources (158)
Events (123555)
Executive appointments (1115)
FDA (20834)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1744)
Gene editing (246)
Generative AI (63)
Gene therapy (749)
GLP-1 (1172)
Government (4961)
Grass and pollen (7)
Guidances (410)
Healthcare (19321)
HIV (82)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (321)
Immuno-oncology (97)
Indications (188)
Infectious disease (3190)
Inflammatory bowel disease (228)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (293)
Interviews (348)
IPO (17111)
IRA (58)
Job creations (4180)
Job search strategy (1564)
JPM (71)
Kidney cancer (21)
Labor market (99)
Layoffs (618)
Leadership (46)
Legal (8584)
Liver cancer (101)
Longevity (33)
Lung cancer (776)
Lymphoma (431)
Machine learning (61)
Management (62)
Manufacturing (1074)
MASH (196)
Medical device (14056)
Medtech (14167)
Mergers & acquisitions (21442)
Metabolic disorders (1611)
mRNA (214)
Multiple sclerosis (194)
NASH (21)
Neurodegenerative disease (430)
Neuropsychiatric disorders (115)
Neuroscience (3379)
Neurotech (1)
NextGen: Class of 2026 (6739)
Non-profit (4606)
Now hiring (77)
Obesity (785)
Opinion (334)
Ovarian cancer (221)
Pain (270)
Pancreatic cancer (297)
Parkinson's disease (367)
Partnered (34)
Patents (605)
Patient recruitment (676)
Peanut (66)
People (62130)
Pharmaceutical (95)
Pharmacy benefit managers (36)
Phase 1 (22863)
Phase 2 (32213)
Phase 3 (24097)
Pipeline (8469)
Policy (347)
Postmarket research (2691)
Preclinical (9677)
Press Release (68)
Prostate cancer (299)
Psychedelics (58)
Radiopharmaceuticals (332)
Rare diseases (1121)
Real estate (6430)
Recruiting (72)
Regulatory (26645)
Reports (57)
Research institute (2487)
Resumes & cover letters (374)
Rett syndrome (36)
RNA editing (24)
RSV (96)
Schizophrenia (186)
Series A (296)
Series B (216)
Service/supplier (14)
Sickle cell disease (114)
Special edition (29)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3860)
State (2)
Stomach cancer (20)
Supply chain (133)
Tariffs (103)
The Weekly (111)
Vaccines (1144)
Venture capital (114)
Weight loss (536)
Women's health (125)
Worklife (21)
Date
Today (133)
Last 7 days (938)
Last 30 days (3281)
Last 365 days (31074)
2026 (12029)
2025 (31085)
2024 (36139)
2023 (40926)
2022 (52113)
2021 (56671)
2020 (55106)
2019 (47820)
2018 (36136)
2017 (33568)
2016 (33169)
2015 (39007)
2014 (32961)
2013 (28077)
2012 (30166)
2011 (30871)
2010 (28889)
Location
Africa (834)
Alabama (92)
Alaska (7)
Arizona (355)
Arkansas (16)
Asia (43593)
Australia (6942)
California (13205)
Canada (3755)
China (1392)
Colorado (565)
Connecticut (573)
Delaware (405)
Europe (94231)
Florida (1997)
Georgia (422)
Hawaii (3)
Idaho (62)
Illinois (1067)
India (91)
Indiana (610)
Iowa (23)
Japan (543)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (75)
Maryland (1594)
Massachusetts (9466)
Michigan (362)
Minnesota (714)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (144)
New Hampshire (84)
New Jersey (3499)
New Mexico (32)
New York (3454)
North Carolina (1730)
North Dakota (9)
Northern California (6585)
Ohio (397)
Oklahoma (24)
Oregon (47)
Pennsylvania (2659)
Puerto Rico (30)
Rhode Island (50)
South America (1201)
South Carolina (86)
South Dakota (2)
Southern California (5205)
Tennessee (212)
Texas (2102)
United States (46830)
Utah (396)
Vermont (1)
Virginia (332)
Washington D.C. (81)
Washington State (1060)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
758,398 Results for "cocrystal pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
April 30, 2026
·
7 min read
Press Releases
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
April 2, 2026
·
5 min read
Press Releases
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
March 31, 2026
·
13 min read
Press Releases
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
March 9, 2026
·
7 min read
Press Releases
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
February 19, 2026
·
6 min read
Press Releases
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
December 2, 2025
·
1 min read
Press Releases
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
October 28, 2025
·
5 min read
Press Releases
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 15, 2025
·
4 min read
Press Releases
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 16, 2025
·
3 min read
Press Releases
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
October 3, 2025
·
1 min read
1 of 75,840
Next
